FDA Approved: SKYRIZI — Original Application (AbbVie Inc.)

View source ↗

Summary

FDA approved SKYRIZI (risankizumab-rzaa) from AbbVie in an original Biologics License Application. The approval covers adults with plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• SKYRIZI (risankizumab-rzaa)

Snippet

ORIG AP for SKYRIZI (RISANKIZUMAB-RZAA)